Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide in early idiopathic Parkinson's disease
NCT00605683Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Nov 2007; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00605683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605683.